These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 23199605

  • 41. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Chinthrajah RS, Purington N, Andorf S, Long A, O'Laughlin KL, Lyu SC, Manohar M, Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ, Nadeau KC.
    Lancet; 2019 Oct 19; 394(10207):1437-1449. PubMed ID: 31522849
    [Abstract] [Full Text] [Related]

  • 42. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD, Siefert A, Fahmy TM, Caplan MJ, Li XM, Sampson HA.
    J Allergy Clin Immunol; 2016 Aug 19; 138(2):536-543.e4. PubMed ID: 27130858
    [Abstract] [Full Text] [Related]

  • 43. IgE, but not IgG4, antibodies to Ara h 2 distinguish peanut allergy from asymptomatic peanut sensitization.
    Hong X, Caruso D, Kumar R, Liu R, Liu X, Wang G, Pongracic JA, Wang X.
    Allergy; 2012 Dec 19; 67(12):1538-46. PubMed ID: 23094689
    [Abstract] [Full Text] [Related]

  • 44. Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy.
    Savilahti EM, Kuitunen M, Valori M, Rantanen V, Bardina L, Gimenez G, Mäkelä MJ, Hautaniemi S, Savilahti E, Sampson HA.
    Pediatr Allergy Immunol; 2014 May 19; 25(3):227-35. PubMed ID: 24393339
    [Abstract] [Full Text] [Related]

  • 45. Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6.
    Hemmings O, Du Toit G, Radulovic S, Lack G, Santos AF.
    J Allergy Clin Immunol; 2020 Sep 19; 146(3):621-630.e5. PubMed ID: 32298698
    [Abstract] [Full Text] [Related]

  • 46. Peanut component Ara h 8 sensitization and tolerance to peanut.
    Asarnoj A, Nilsson C, Lidholm J, Glaumann S, Östblom E, Hedlin G, van Hage M, Lilja G, Wickman M.
    J Allergy Clin Immunol; 2012 Aug 19; 130(2):468-72. PubMed ID: 22738678
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Immunochemical characterisation of structure and allergenicity of peanut 2S albumins using different formats of immunoassays.
    Bernard H, Drumare MF, Guillon B, Paty E, Scheinmann P, Wal JM.
    Anal Bioanal Chem; 2009 Sep 19; 395(1):139-46. PubMed ID: 19462164
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Peanut oral immunotherapy in a pediatric allergy clinic: Patient factors associated with clinical outcomes.
    Guarnieri KM, Slack IF, Gadoury-Lévesque V, Eapen AA, Andorf S, Lierl MB.
    Ann Allergy Asthma Immunol; 2021 Aug 19; 127(2):214-222.e4. PubMed ID: 33839246
    [Abstract] [Full Text] [Related]

  • 51. Clinical factors associated with peanut allergy in a high-risk infant cohort.
    Sicherer SH, Wood RA, Perry TT, Jones SM, Leung DYM, Henning AK, Dawson P, Burks AW, Lindblad R, Sampson HA.
    Allergy; 2019 Nov 19; 74(11):2199-2211. PubMed ID: 31120555
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.
    Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Noval Rivas M, Koleoglou KJ, Chatila TA, Schneider LC, Rachid R, Umetsu DT, Oettgen HC.
    J Allergy Clin Immunol; 2014 Dec 19; 134(6):1310-1317.e6. PubMed ID: 25042981
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Ara h 7 isoforms share many linear epitopes: Are 3D epitopes crucial to elucidate divergent abilities?
    Ehlers AM, Klinge M, Suer W, Weimann Y, Knulst AC, Besa F, Le TM, Otten HG.
    Clin Exp Allergy; 2019 Nov 19; 49(11):1512-1519. PubMed ID: 31520442
    [Abstract] [Full Text] [Related]

  • 56. RBL cells expressing human Fc epsilon RI are a sensitive tool for exploring functional IgE-allergen interactions: studies with sera from peanut-sensitive patients.
    Dibbern DA, Palmer GW, Williams PB, Bock SA, Dreskin SC.
    J Immunol Methods; 2003 Mar 01; 274(1-2):37-45. PubMed ID: 12609531
    [Abstract] [Full Text] [Related]

  • 57. Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children.
    Beyer K, Grabenhenrich L, Härtl M, Beder A, Kalb B, Ziegert M, Finger A, Harandi N, Schlags R, Gappa M, Puzzo L, Röblitz H, Millner-Uhlemann M, Büsing S, Ott H, Lange L, Niggemann B.
    Allergy; 2015 Jan 01; 70(1):90-8. PubMed ID: 25308885
    [Abstract] [Full Text] [Related]

  • 58. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.
    Kulis M, Saba K, Kim EH, Bird JA, Kamilaris N, Vickery BP, Staats H, Burks AW.
    J Allergy Clin Immunol; 2012 Apr 01; 129(4):1159-62. PubMed ID: 22236732
    [Abstract] [Full Text] [Related]

  • 59. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT.
    J Allergy Clin Immunol; 2013 Dec 01; 132(6):1368-74. PubMed ID: 24176117
    [Abstract] [Full Text] [Related]

  • 60. Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time.
    Flinterman AE, van Hoffen E, den Hartog Jager CF, Koppelman S, Pasmans SG, Hoekstra MO, Bruijnzeel-Koomen CA, Knulst AC, Knol EF.
    Clin Exp Allergy; 2007 Aug 01; 37(8):1221-8. PubMed ID: 17651153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.